Olympic bronze medalist Jenny Simpson announced she will no longer be able to run after being diagnosed with a rare congenital heart condition following a cardiac arrest in June. The 39-year-old athlete collapsed while pacing a group of young runners in Raleigh, North Carolina, leading to the discovery of arrhythmogenic right ventricular cardiomyopathy (ARVC). Simpson, who won bronze in the 1,500-meter race at the 2016 Rio Olympics, had recently transitioned to a role as chief running officer for the company Fleet Feet.
The cardiac event occurred on June 16, while Simpson was at an event with Fleet Feet CEO Joey Pointer and his wife, Ivy Pointer, a pediatric intensive care physician. Because the Pointers have a child with congenital heart disease, they had an automated external defibrillator (AED) on hand. Ivy Pointer and other bystanders performed CPR until emergency responders arrived. Simpson subsequently suffered a second cardiac arrest and spent several days on life support at Duke University Medical Center.
Doctors diagnosed Simpson with ARVC, a condition where the heart repairs damage with tissue that does not properly conduct electricity in the right ventricle. While running did not cause the disease, Simpson's cardiologist noted that the high physical demand of her career eventually revealed the condition when the heart's electrical system failed during activity. To manage the condition, Simpson has had a defibrillator and pacemaker surgically implanted and remains under the regular care of a cardiologist.
For the broader running community and the public, this event demonstrates the critical role of immediate medical intervention. The presence of an AED and a trained physician at the scene were cited as decisive factors in Simpson's survival. An AED is a portable electronic device that automatically diagnoses life-threatening cardiac arrhythmias and can treat them through defibrillation. The use of this technology, which typically costs between $1,200 and $2,000 per unit for organizations or individuals, represents the difference between a fatal event and a survivable one during sudden cardiac arrest.
Simpson has stated she will continue her employment with Fleet Feet and is currently recovering at home. She noted on social media that there is still much to learn about her long-term recovery process and the specific limitations she will face in her daily life without running. What happens next involves ongoing medical monitoring to ensure her implanted device functions correctly and to manage the progression of ARVC. No specific dates for further procedures or a return to full-time work duties were reported.